Showing results (2301-2310 of 5,702) with videos related to
Sort By:
Pageof 571
The Oncologist|September 6, 2022
Prognostic Awareness and Discussions of Incurability in Patients with Pretreated Non-Small Cell Lung Cancer and Caregivers: A Prospective Cohort StudyTakaaki Hasegawa, Toru Okuyama, Takehiro Uemura, et al.The Oncologist|October 11, 2022
Evaluation of Seropositivity After Standard Doses of Vaccination Against SARS-CoV-2 in Patients With Early Breast Cancer Receiving Adjuvant TreatmentJinyong Kim, Euijin Chang, Song Yi Park, et al.The Oncologist|September 13, 2022
EGFR Mutations and PD-L1 Expression in Early-Stage Non-Small Cell Lung Cancer: A Real-World Data From a Single Center in BrazilIcaro Alves Pinto, Rodrigo de Oliveira Cavagna, Aline Larissa Virginio da Silva, et al.The Oncologist|September 20, 2022
Inhibition of the Phosphatidylinositol-3 Kinase Pathway Using Bimiralisib in Loss-of-Function NOTCH1-Mutant Head and Neck CancerFaye M Johnson, Filip Janku, Mohamed A Gouda, et al.The Oncologist|September 20, 2022
The Role of Race and Insurance Status in Access to Genetic Counseling and Testing Among High-Risk Breast Cancer PatientsJihoon J Choi, Tsion Fikre, Alexandra Fischman, et al.The Oncologist|September 20, 2022
KRAS Mutation Variants and Co-occurring PI3K Pathway Alterations Impact Survival for Patients with Pancreatic Ductal AdenocarcinomasAdam C Diehl, Lindsay M Hannan, David B Zhen, et al.The Oncologist|September 20, 2022
Grade 3/4 Adverse Event Costs of Immuno-oncology Combination Therapies for Previously Untreated Advanced Renal Cell CarcinomaBradley McGregor, Daniel M Geynisman, Mauricio Burotto, et al.The Oncologist|October 9, 2019
Real-World Adherence in Patients with Metastatic Colorectal Cancer Treated with Trifluridine plus Tipiracil or RegorafenibAnuj K Patel, Victoria Barghout, Mihran A Yenikomshian, et al.The Oncologist|August 29, 2022
Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on RaceRaquel Zimmerman, Mehmet A Bilen, Elisabeth I Heath, et al.The Oncologist|May 1, 2019
Sex Differences in Tolerability to Anti-Programmed Cell Death Protein 1 Therapy in Patients with Metastatic Melanoma and Non-Small Cell Lung Cancer: Are We All Equal?Narjust Duma, Azzouqa Abdel-Ghani, Siddhartha Yadav, et al.Pageof 571